The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic Information
Publication number:
EP3551629
WO Application Number:
US2017065270
Type:
European Patent Granted for NL
Status:
Patent in Force
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP17879038.2
WO Publication Number:
WO2018107004
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
United States of America (US)
Publications:
Dates
Filing date:
08/12/2017
Grant date:
15/11/2023
EP Publication Date:
16/10/2019
WO Publication Date:
14/06/2018
Claims Translations Received Date:
Claims Translation B1 Received Date:
07/02/2024
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
15/11/2023
EP B1 Publication Date:
15/11/2023
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
07/12/2037
Lapsed By Expiration Date:
Patent Validated Date:
15/02/2024
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:
Applicant/holder
From:
04/06/2024
Name:
The U.S.A. as represented by the Secretary, Department of Health and Human Services
Address:
Office of Technology Transfer
National Institutes of Health
6701 Rockledge Drive, Suite 700, 20892, Bethesda, MD, United States of America (US)
From:
15/11/2023
Name:
Lixte Biotechnology, Inc.
Address:
680 E. Colorado Blvd., Suite 180, Pasadena, CA 91101, United States of America (US)
Historical Applicant/holder
From:
15/11/2023
To:
04/06/2024
Name:
The U.S.A. as represented by the Secretary, Department of Health and Human Services
Address:
Office of Technology Transfer
National Institutes of Health
6011 Executive Boulevard, Suite 325
MSC 7660, Bethesda, MD 20892-7660, United States of America (US)